Psychiatrists and Psychologists

About Us

The 37th Euro Congress on Psychiatrists and Psychologists, scheduled for June 28–29, 2027, in Paris, France, is an international platform dedicated to advancing knowledge, research, and clinical practice in the fields of psychiatry and psychology. The congress brings together psychiatrists, psychologists, mental health professionals, researchers, clinicians, academics, therapists, and healthcare experts from around the world to exchange knowledge, share experiences, and discuss the latest developments in mental healthcare.

The congress will explore a broad range of topics covering mental health, psychiatry, psychology, behavioral health, neuroscience, psychotherapy, psychopharmacology, neuropsychiatry, and innovative approaches to diagnosis and treatment. Special attention will be given to emerging developments that can support early diagnosis, personalized care, effective treatment strategies, and improved quality of life for individuals experiencing mental health challenges. The congress will  highlight modern approaches such as digital mental health, telepsychiatry, artificial intelligence, digital therapeutics, brain science, and evidence-based psychological interventions. Through keynote presentations, plenary sessions, oral and poster presentations, interactive discussions, workshops, and networking opportunities, participants will have the opportunity to present their research, exchange clinical insights, and learn about innovative approaches in mental health and behavioral science.

The 37th Euro Congress on Psychiatrists and Psychologists aims to create a supportive environment for scientific exchange and professional development while encouraging new ideas and collaborative solutions for the challenges facing modern mental healthcare. Hosted in Paris, France, the congress provides an inspiring international setting for professionals to connect, collaborate, and contribute to the future of psychiatry and psychology. Through shared knowledge and interdisciplinary cooperation, the congress seeks to support better mental health outcomes and promote a more effective, accessible, and patient-centered future for mental healthcare.

Sessions

Advances in Clinical Psychiatry and Mental Health

Recent developments in clinical psychiatry are transforming the diagnosis, treatment, and management of mental health conditions. The session explores evidence-based practices, early intervention, personalized treatment, and integrated approaches to patient care. Key challenges such as treatment gaps, stigma, patient engagement, and continuity of care will be discussed. Emerging developments in neuroscience and digital healthcare will also be highlighted. Experts will share research findings, clinical experiences, and innovative approaches from different areas of psychiatry. Multidisciplinary collaboration between psychiatrists, psychologists, researchers, and healthcare professionals will be encouraged. Discussions will focus on improving accessibility, treatment effectiveness, and quality of mental health services.

Depression, Anxiety and Mood Disorders

Depression, anxiety, and mood disorders remain major challenges in mental healthcare, affecting emotional well-being and daily functioning. The session explores current approaches to diagnosis, prevention, and treatment of these conditions. Discussions will cover risk factors, clinical symptoms, comorbidities, psychotherapy, pharmacological treatments, and integrated care. Particular attention will be given to treatment-resistant depression, recurrent mood disorders, panic disorders, and generalized anxiety. Early identification, relapse prevention, treatment adherence, and patient monitoring will also be addressed. Digital interventions and remote psychological support may provide additional opportunities for improving access to care. Experts will share clinical experiences and research perspectives on effective management strategies.

Schizophrenia and Psychotic Disorders

Schizophrenia and other psychotic disorders require comprehensive approaches to diagnosis, treatment, and long-term recovery. Discussions will focus on early recognition, first-episode psychosis, symptom management, and relapse prevention. Biological, psychological, and social factors associated with psychotic disorders will also be explored. Antipsychotic medications, psychosocial interventions, rehabilitation, family support, and coordinated care will receive attention. Emerging research in neurobiology, biomarkers, brain imaging, and personalized treatment may provide new perspectives. Treatment adherence and strategies for improving quality of life will also be considered. Reducing stigma and promoting social inclusion remain important aspects of recovery-oriented care.

Bipolar Disorder and Personality Disorders

Bipolar disorder and personality disorders present complex challenges requiring careful assessment and individualized treatment. The session examines clinical characteristics, diagnosis, comorbidities, risk assessment, and long-term management strategies. Pharmacological approaches, psychotherapy, behavioral interventions, and psychoeducation will be discussed. Emotional regulation, impulsivity, interpersonal difficulties, and treatment engagement will receive particular attention. The importance of therapeutic relationships, family involvement, and multidisciplinary care will also be highlighted. Emerging personalized approaches and digital monitoring may support improved treatment management. Early intervention and relapse prevention will remain important areas of discussion.

Neuroscience and Neurobiology of Mental Disorders

Advances in neuroscience are providing deeper insights into the biological mechanisms underlying mental health conditions. The session explores neural circuits, neurotransmitter systems, neuroplasticity, genetics, epigenetics, and interactions between biological and environmental factors. Research related to depression, schizophrenia, anxiety, bipolar disorder, and neurodevelopmental conditions will be considered. Brain imaging, biomarkers, and computational neuroscience may offer new opportunities for understanding psychiatric disorders. Discussions will examine how scientific discoveries can be translated into improved diagnostic and therapeutic approaches. Collaboration between psychiatrists, psychologists, neuroscientists, geneticists, and researchers will be encouraged. Emerging neuroscience-based approaches may contribute to more precise and personalized mental healthcare.

Psychotherapy and Evidence-Based Behavioral Interventions

Evidence-based psychotherapy and behavioral interventions play an important role in modern mental healthcare. Discussions will cover cognitive behavioral therapy, interpersonal therapy, behavioral activation, mindfulness-based approaches, acceptance-based interventions, and supportive psychotherapy. Treatment planning, therapeutic relationships, patient engagement, and evaluation of clinical outcomes will also be explored. Attention will be given to adapting psychological interventions for different age groups, cultural backgrounds, and clinical settings. Remote and digital delivery models may provide additional opportunities to improve accessibility. The integration of psychotherapy with psychiatric treatment will also be considered where appropriate. Experts will share practical experiences and research findings related to effective psychological care.

Cognitive Behavioral Therapy and Third-Wave Therapies

Cognitive Behavioral Therapy and third-wave approaches continue to play an important role in psychological treatment. The session explores CBT applications across depression, anxiety, trauma-related conditions, and other mental health concerns. Acceptance and Commitment Therapy, Dialectical Behavior Therapy, and Mindfulness-Based Cognitive Therapy will also be discussed. Key areas include cognitive restructuring, emotional regulation, behavioral change, acceptance, mindfulness, and psychological flexibility. Evidence supporting these approaches and challenges in treatment implementation will receive attention. Digital and remote delivery of CBT-based interventions may offer new opportunities to expand access to psychological support. Experts will discuss practical applications and emerging research in behavioral therapies.

Trauma, PTSD and Psychological Resilience

Traumatic experiences can have lasting effects on emotional well-being, behavior, relationships, and overall mental health. The session focuses on PTSD, acute stress, complex trauma, childhood adversity, grief, and psychological consequences of violence or disasters. Evidence-based trauma-focused interventions and trauma-informed care will be explored. Early intervention, emotional regulation, coping strategies, social support, and resilience-building approaches will receive particular attention. Discussions will also consider the relationship between trauma, depression, anxiety, substance use, and other mental health conditions. Experts will share approaches for creating safe and supportive therapeutic environments. Recovery-oriented strategies can help individuals strengthen coping abilities and rebuild psychological well-being.

Child and Adolescent Psychiatry and Psychology

Mental health during childhood and adolescence can influence emotional development, learning, relationships, and well-being throughout life. The session addresses anxiety, depression, behavioral difficulties, self-harm, eating disorders, and other psychological challenges affecting young people. Early identification, psychological assessment, family-based interventions, and school-based support will be discussed. Psychotherapy and appropriate psychiatric care will also receive attention. Family relationships, education, social environments, and digital media can influence adolescent mental health and will be considered. Prevention, resilience, emotional development, and healthy coping skills will remain important areas of focus. Collaboration between families, schools, healthcare professionals, and community services will be encouraged.

Neurodevelopmental Disorders: Autism and ADHD

Autism spectrum disorder and ADHD require individualized approaches to assessment, support, and long-term care. Discussions will focus on early recognition, developmental assessment, differential diagnosis, and co-occurring conditions. Behavioral interventions, psychological support, educational strategies, family involvement, and appropriate medical management will be explored. Anxiety, depression, sleep difficulties, and sensory challenges that may occur alongside neurodevelopmental conditions will also receive attention. Multidisciplinary collaboration among psychiatrists, psychologists, pediatricians, educators, therapists, and families will be highlighted. Emerging developments in genetics, neuroscience, digital assessment, and personalized interventions may provide new opportunities for support. The importance of recognizing individual strengths while addressing clinical and functional needs will be emphasized.

Addiction Psychiatry and Substance Use Disorders

Substance use disorders and behavioral addictions represent significant challenges for individuals, families, and healthcare systems. The session explores biological, psychological, social, and environmental factors contributing to addictive behaviors. Topics include alcohol and drug dependence, medication misuse, tobacco and nicotine use, gaming-related problems, gambling, and emerging behavioral addictions. Screening, diagnosis, risk assessment, pharmacological treatment, psychotherapy, and relapse prevention will be discussed. The relationship between addiction and depression, anxiety, trauma, and psychotic disorders will also be examined. Family support and community-based recovery services can play an important role in long-term care. Harm-reduction strategies and patient-centered approaches will receive attention.

Geriatric Psychiatry, Dementia and Cognitive Health

Mental health and cognitive well-being are essential components of healthy aging and quality of life. The session explores depression, anxiety, dementia, delirium, behavioral symptoms, sleep difficulties, loneliness, and other concerns affecting older adults. Comprehensive assessment can help distinguish psychiatric symptoms from neurological and medical conditions. Cognitive screening, neuropsychological assessment, medication management, psychotherapy, rehabilitation, and caregiver support will be discussed. Emerging developments in dementia research, brain health, biomarkers, and digital monitoring may also be explored. Maintaining independence, dignity, social connection, and quality of life will remain central themes. Collaboration among psychiatrists, psychologists, neurologists, geriatricians, caregivers, and community services will be encouraged

Psychopharmacology and Emerging Psychiatric Treatments

Advances in psychopharmacology continue to expand treatment options for individuals with psychiatric disorders. The session examines current pharmacological approaches, treatment selection, medication safety, tolerability, adherence, and long-term management. Antidepressants, antipsychotics, mood stabilizers, anxiolytic treatments, and approaches for treatment-resistant conditions will be discussed. Individual patient characteristics, comorbidities, and previous treatment responses can guide personalized treatment decisions. Emerging areas such as precision medicine, pharmacogenomics, biomarkers, and data-driven treatment approaches will also receive attention. Experts will consider new therapeutic developments while emphasizing clinical evidence and patient safety

Precision Psychiatry and Personalized Mental Healthcare

Precision psychiatry is emerging as an important approach to understanding individual differences in mental health and treatment response. The session explores the potential use of biological, psychological, genetic, environmental, and behavioral information in personalized care. Topics include biomarkers, genetics, neuroimaging, digital phenotyping, patient-reported outcomes, and data-driven approaches. Personalized strategies may support earlier identification of risk and more targeted treatment decisions. Discussions will also address challenges related to data quality, validation, accessibility, ethics, privacy, and health equity. Collaboration between psychiatry, psychology, neuroscience, genetics, and data science will be encouraged. Experts will examine both the opportunities and limitations of precision approaches in clinical practice.

Digital Psychiatry, Telepsychiatry and Digital Therapeutics

Digital technologies are creating new opportunities to expand access to psychiatric and psychological services. The session explores telepsychiatry, digital therapeutics, mobile applications, online counseling, remote monitoring, and virtual psychological interventions. Discussions will consider the effectiveness, accessibility, usability, and clinical integration of digital mental health solutions. Digital assessment, patient monitoring, remote treatment, and technology-supported psychological care will also be addressed. Privacy, cybersecurity, informed consent, digital literacy, and responsible implementation remain important considerations. Particular attention may be given to underserved populations and individuals facing barriers to traditional mental health services. Experts will discuss how technology can complement professional care while maintaining human-centered treatment.

Artificial Intelligence and Technology in Mental Healthcare

Artificial intelligence is creating new possibilities across diagnosis, clinical decision support, risk assessment, monitoring, and personalized mental healthcare. The session explores emerging applications of AI and advanced technologies in psychiatry and psychology. Discussions will address digital phenotyping, predictive models, natural-language analysis, personalized interventions, and technology-supported patient monitoring. Data quality, algorithmic bias, transparency, privacy, cybersecurity, and clinical validation will also receive attention. Experts will consider how AI can support healthcare professionals while maintaining appropriate human oversight and patient safety. Ethical considerations and responsible implementation will be important areas of discussion. The integration of AI with existing clinical practices may improve efficiency and access when appropriately evaluated.

Neuroimaging, Biomarkers and Advanced Diagnostics

Advances in neuroimaging, genetics, molecular research, and biomarker discovery are creating new opportunities for psychiatric research and diagnosis. The session explores brain imaging, electrophysiology, genetic information, inflammatory markers, and other emerging diagnostic approaches. These technologies may contribute to improved understanding of disease mechanisms, early detection, prognosis, and treatment response. Researchers will discuss the potential applications of advanced diagnostics across different psychiatric and neurological conditions. Challenges including reproducibility, validation, cost, accessibility, and clinical interpretation will also be considered. Collaboration among psychiatry, psychology, neuroscience, radiology, genetics, and data science will be encouraged. Translating research findings into reliable clinical tools remains an important priority.

Forensic Psychiatry, Psychology and Mental Health Law

Forensic psychiatry and psychology examine the complex relationship between mental health and the legal system. The session covers forensic assessment, risk evaluation, mental capacity, competency, rehabilitation, criminal responsibility, and violence prevention. Ethical issues involving confidentiality, informed consent, professional responsibility, and human rights will also be discussed. Attention will be given to mental healthcare within correctional and secure settings. Experts will explore approaches to risk management while maintaining individualized and evidence-based care. The psychological impact of legal processes and the needs of individuals involved in legal proceedings may also be considered. Collaboration between mental health professionals, legal practitioners, social services, and correctional systems will be highlighted.

Suicide Prevention, Crisis Intervention and Mental Health Awareness

Suicide prevention and crisis intervention remain essential components of comprehensive mental healthcare. The session explores risk assessment, early identification, crisis response, safety planning, psychological support, and appropriate referral to mental health services. Discussions will also address the importance of reducing stigma and encouraging individuals to seek professional support at an early stage. Community-based prevention programs, school and workplace initiatives, and public mental health awareness strategies will be considered. Particular attention may be given to vulnerable populations and individuals experiencing severe psychological distress. Collaboration among psychiatrists, psychologists, primary-care professionals, educators, families, and community organizations will be encouraged. Responsible approaches to communication and postvention support will also be highlighted.

Global Mental Health, Community Care and Integrated Healthcare

Global mental health requires accessible, affordable, and integrated services that respond to the diverse needs of communities. The session explores community-based care, primary healthcare integration, prevention, rehabilitation, and multidisciplinary service models. Discussions will address challenges such as workforce shortages, stigma, social inequality, limited resources, and unequal access to specialist services. Digital tools, telepsychiatry, peer support, and culturally appropriate interventions may provide additional opportunities to expand care. Collaboration between governments, healthcare institutions, universities, researchers, and community organizations will be emphasized. Successful models of integrated mental healthcare can strengthen continuity of care and improve patient outcomes. Special attention will be given to vulnerable and underserved populations.

Market Analysis

The market for psychiatry, psychology, and mental healthcare is experiencing sustained growth, driven by the increasing prevalence of mental health conditions, greater public awareness, reduced stigma, and growing recognition of mental well-being as an essential component of overall healthcare. According to the World Health Organization, nearly 1 in 7 people globally were living with a mental disorder in 2021, representing approximately 1.1 billion people, with anxiety and depressive disorders among the most common conditions. Despite the availability of effective prevention and treatment approaches, a large proportion of affected individuals still do not receive adequate care, creating a substantial unmet need for psychiatric and psychological services. This growing demand is encouraging healthcare organizations, governments, research institutions, pharmaceutical companies, and technology providers to invest in improved diagnosis, treatment, prevention, and community-based care. The European market is particularly significant because of its established healthcare infrastructure, increasing mental health awareness, and expansion of integrated and community-based services. One market analysis estimates that the European mental health market was valued at approximately USD 115.5 billion in 2025 and could reach around USD 141.8 billion by 2034, reflecting continued demand for professional mental health services. Depression and anxiety represent major areas of demand, while schizophrenia, bipolar disorder, substance-use disorders, trauma-related conditions, neurodevelopmental disorders, dementia, and other psychiatric conditions continue to create opportunities for specialized clinical and research services.

Technology is becoming an increasingly important component of this expanding market. Telepsychiatry, digital therapeutics, online psychotherapy, mobile mental health applications, artificial intelligence, remote monitoring, digital assessments, and data-driven personalized care are creating new possibilities for improving accessibility and extending mental health services beyond traditional clinical settings. Recent market research projects strong growth in digital mental health, with one 2026 estimate placing the global market at approximately USD 11.7 billion in 2026 and USD 25.1 billion by 2032, representing a CAGR of about 13.5%. The European Union is also increasingly examining the economic and healthcare potential of digital technologies, with a 2026 European Commission report identifying mental health platforms among digital health technologies with significant potential for healthcare cost avoidance. Alongside technological innovation, there is increasing interest in precision psychiatry, biomarkers, neuroimaging, psychopharmacology, neuroscience, evidence-based psychotherapy, suicide prevention, child and adolescent mental health, and integrated healthcare models. These developments create strong opportunities for collaboration among psychiatrists, psychologists, neuroscientists, clinicians, researchers, pharmaceutical and biotechnology companies, digital health organizations, and policymakers. The 37th Euro Congress on Psychiatrists and Psychologists, scheduled for June 28–29, 2027, in Paris, France, is therefore positioned within a rapidly evolving professional and scientific landscape. By providing a platform for researchers, healthcare professionals, academics, and industry representatives to exchange research findings, discuss emerging therapies, explore technological innovations, and develop professional collaborations, the congress can support knowledge transfer and help identify future opportunities in the global mental healthcare sector.

Past Conference Report

Euro Psychiatry 2026

The 36th Euro Congress on Psychiatrists and Psychologists was held in Paris, France, in 2026, continuing the congress’s tradition of bringing together professionals from psychiatry, psychology, neuroscience, behavioral health, and related fields. The previous edition focused on “Collaborative Care: Bridging Clinical Psychiatry and Psychological Science,” highlighting the importance of integrating psychiatric and psychological approaches in modern mental healthcare.

The congress provided a platform for experts, researchers, clinicians, academics, and mental health professionals to exchange knowledge, present research findings, and discuss emerging developments in diagnosis, treatment, and patient care. Key areas included psychiatric disorders, anxiety and depression, neurodevelopmental disorders, addiction psychiatry, psychopharmacology, behavioral neuroscience, digital mental health, AI-driven approaches, trauma-informed care, and precision psychiatry. The event also encouraged interdisciplinary collaboration and professional networking among participants from different countries and backgrounds.

Building on the success and scientific discussions of previous editions, the 37th Euro Congress on Psychiatrists and Psychologists, scheduled for June 28–29, 2027, in Paris, France, aims to further advance international collaboration and provide a valuable platform for sharing innovative research, clinical experiences, and emerging solutions in psychiatry and psychology.